Key result
Roxithromycin significantly reduced the expansion rate of small abdominal aortic aneurysms (MD -0.86 mm; 95% CI -1.57 to -0.14), whereas beta-blockers showed no significant protective effect.
Why the study?
Does medical treatment (antibiotics or beta-blockers) reduce aneurysm expansion or the need for surgery in patients with small abdominal aortic aneurysms?
Population
1558 participants across 7 randomised trials with small abdominal aortic aneurysms (diameter ≤ 55 mm).
Comparison
Medical treatment intended to retard aneurysm… vs Placebo treatment, alternative medical…
Design
Meta-analysis, Randomised trials
Authors
Loading...
Supports surveillance over early repair for small AAAs; reinforces RCT evidence against routine intervention below 5.5 cm.
Meta-Analysis (n=1,558)
Does medical treatment (antibiotics or beta-blockers) reduce aneurysm expansion or the need for surgery in patients with small abdominal aortic aneurysms?
Mean Difference: -0.86 (95% CI -1.57–-0.14)
There is limited evidence that antibiotics slightly retard small AAA expansion, while propranolol is poorly tolerated and ineffective, highlighting a lack of high-quality evidence for medical therapies in this population.
Rughani et al. (2012) conducted a meta-analysis in Small abdominal aortic aneurysms (n=1,558). Medical treatment (antibiotics or beta-blockers) vs. Placebo, alternative medical treatment, or imaging surveillance alone was evaluated on Mean difference in aneurysm diameter expansion (roxithromycin vs control) (MD -0.86, 95% CI -1.57 to -0.14). Roxithromycin significantly reduced the expansion rate of small abdominal aortic aneurysms (MD -0.86 mm; 95% CI -1.57 to -0.14), whereas beta-blockers showed no significant protective effect.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: